Search Results | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Selecting Patients for Treatment with Epidermal Growth Factor Tyrosine Kinase Inhibitors

Philip D. Bonomi, Lela Buckingham, John Coon

Clin Cancer Res (2007) 13 (15): 4606s–4612s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0332

Published: 01 August 2007

View article

Journal Articles

Is There a Role for Cetuximab in Non–Small Cell Lung Cancer?

Daniel Morgensztern, Ramaswamy Govindan

Clin Cancer Res (2007) 13 (15): 4602s–4605s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0545

Published: 01 August 2007

View article

Journal Articles

Erlotinib: Recent Clinical Results and Ongoing Studies in Non–Small Cell Lung Cancer

Roman Perez-Soler

Clin Cancer Res (2007) 13 (15): 4589s–4592s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0541

Published: 01 August 2007

View article

Journal Articles

Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference

Thomas J. Lynch, Philip D. Bonomi, Charles Butts, Angela M. Davies, Jeffrey Engelman, Ramaswamy Govindan, Roy S. Herbst, John V. Heymach, Bruce E. Johnson, Renato G. Martins, Roman Perez-Soler, Gregory J. Riely, Alan B. Sandler, Lecia V. Sequist, Mark A. Socinski, Kwok-Kin Wong, Carol S. Hart

Clin Cancer Res (2007) 13 (15): 4583s–4588s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0716

Published: 01 August 2007

View article

Journal Articles

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Vandetanib (ZD6474) and AZD2171 in Lung Cancer

Emer O. Hanrahan, John V. Heymach

Clin Cancer Res (2007) 13 (15): 4617s–4622s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0539

Published: 01 August 2007

View article

Journal Articles

Bevacizumab in Non–Small Cell Lung Cancer

Alan Sandler

Clin Cancer Res (2007) 13 (15): 4613s–4616s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0647

Published: 01 August 2007

View article

Journal Articles

Antagonism of Platelet-Derived Growth Factor Receptor in Non–Small Cell Lung Cancer: Rationale and Investigations

Julie E. Bauman, Keith D. Eaton, Renato G. Martins

Clin Cancer Res (2007) 13 (15): 4632s–4636s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0212

Published: 01 August 2007

View article

Journal Articles

HKI-272 in Non–Small Cell Lung Cancer

Kwok-Kin Wong

Clin Cancer Res (2007) 13 (15): 4593s–4596s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0369

Published: 01 August 2007

View article

Journal Articles

Rationale for a Phase I Trial of Erlotinib and the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) for Patients with Relapsed Non–Small Cell Lung Cancer

Bruce E. Johnson, David Jackman, Pasi A. Jänne

Clin Cancer Res (2007) 13 (15): 4628s–4631s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0717

Published: 01 August 2007

View article

Journal Articles

The Role of Phosphoinositide 3-Kinase Pathway Inhibitors in the Treatment of Lung Cancer

Jeffrey A. Engelman

Clin Cancer Res (2007) 13 (15): 4637s–4640s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0653

Published: 01 August 2007

View article

Journal Articles

L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer

Randeep Sangha, Charles Butts

Clin Cancer Res (2007) 13 (15): 4652s–4654s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0213

Published: 01 August 2007

View article

Journal Articles

Incorporating Bortezomib into the Treatment of Lung Cancer

Angela M. Davies, Primo N. Lara, Jr., Philip C. Mack, David R. Gandara

Clin Cancer Res (2007) 13 (15): 4647s–4651s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0334

Published: 01 August 2007

View article

Journal Articles

Enzastaurin, a Protein Kinase Cβ–Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer

Roy S. Herbst, Yun Oh, Asavari Wagle, Michael Lahn

Clin Cancer Res (2007) 13 (15): 4641s–4646s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0538

Published: 01 August 2007

View article

Journal Articles

Antibodies to the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer: Current Status of Matuzumab and Panitumumab

Mark A. Socinski

Clin Cancer Res (2007) 13 (15): 4597s–4601s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0335

Published: 01 August 2007

View article

Journal Articles

Vascular Endothelial Growth Factor Trap in Non–Small Cell Lung Cancer

Gregory J. Riely, Vincent A. Miller

Clin Cancer Res (2007) 13 (15): 4623s–4627s.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0544

Published: 01 August 2007

View article

NARROW

Selecting Patients for Treatment with Epidermal Growth Factor Tyrosine Kinase Inhibitors

Is There a Role for Cetuximab in Non–Small Cell Lung Cancer?

Erlotinib: Recent Clinical Results and Ongoing Studies in Non–Small Cell Lung Cancer

Novel Agents in the Treatment of Lung Cancer: Fourth Cambridge Conference

Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Vandetanib (ZD6474) and AZD2171 in Lung Cancer

Bevacizumab in Non–Small Cell Lung Cancer

Antagonism of Platelet-Derived Growth Factor Receptor in Non–Small Cell Lung Cancer: Rationale and Investigations

HKI-272 in Non–Small Cell Lung Cancer

Rationale for a Phase I Trial of Erlotinib and the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) for Patients with Relapsed Non–Small Cell Lung Cancer

The Role of Phosphoinositide 3-Kinase Pathway Inhibitors in the Treatment of Lung Cancer

L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer

Incorporating Bortezomib into the Treatment of Lung Cancer

Enzastaurin, a Protein Kinase Cβ–Selective Inhibitor, and Its Potential Application as an Anticancer Agent in Lung Cancer

Antibodies to the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer: Current Status of Matuzumab and Panitumumab

Vascular Endothelial Growth Factor Trap in Non–Small Cell Lung Cancer

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only